Corvus Pharmaceuticals, Inc. (CRVS) Capital expenditures 2016–2025
Corvus Pharmaceuticals, Inc. (CRVS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$174,000FY2025 · since FY2016: $2.2M → $174,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $174,000 | — |
| FY2023 | $34,000 | -87.4% |
| FY2022 | $269,000 | +5280.0% |
| FY2021 | $5,000 | -93.4% |
| FY2020 | $76,000 | +204.0% |
| FY2019 | $25,000 | -93.0% |
| FY2018 | $355,000 | +33.5% |
| FY2017 | $266,000 | -87.9% |
| FY2016 | $2.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice